Certain Common Stock of Jounce Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 9-MAY-2021.
Details:
The executive officers, directors and certain of significant stockholders have entered that they will not sell, directly or indirectly, any shares of common stock for a period of 60 days after the date of the pricing of the offering, without the prior approval of Cowen and Company, LLC.